The Use of 1.5-Anhydroglucitol for Monitoring Glycemic Control in Islet Transplant Recipients
Peixoto, Eduardo Moraes Leao, Bozkurt, Nujen Colak, Messinger, Shari, Del Olmo García, Maria Isabel, Lauriola, Vincenzo, Corrales, Andrea, Herrada, Eva, Ricordi, Camillo, Alejandro, Rodolfo
Published in Cell transplantation (01.01.2014)
Published in Cell transplantation (01.01.2014)
Get full text
Journal Article
A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up
Ciancio, Gaetano, Burke, George W., Gaynor, Jeffrey J., Roth, David, Kupin, Warren, Rosen, Anne, Cordovilla, Tatiana, Tueros, Lissett, Herrada, Eva, Miller, Joshua
Published in Clinical transplantation (01.03.2008)
Published in Clinical transplantation (01.03.2008)
Get full text
Journal Article
Hepatic hematoma after islet cell transplantation
Bozkurt, Nujen Colak, Leao Peixoto, Eduardo Moraes, Froud, Tatiana, Herrada, Eva, Corrales, Andrea, Ricordi, Camillo, Alejandro, Rodolfo
Published in Transplantation (27.06.2013)
Published in Transplantation (27.06.2013)
Get more information
Journal Article
S.40. Immune Monitoring in Clinical Islet Transplantation by Assessment of Induced-Activation of CD4+T-Lymphocytes
Mineo, Davide, Froud, Tatiana, Baidal, David, Herrada, Eva, Carreno, Manuel, Ruiz, Phillip, Ricordi, Camillo, Meneghini, Luigi, Alejandro, Rodolfo
Published in Clinical immunology (Orlando, Fla.) (2009)
Published in Clinical immunology (Orlando, Fla.) (2009)
Get full text
Journal Article
Campath-1H induction therapy in African American and Hispanic first renal transplant recipients: 3-year actuarial follow-up
Ciancio, Gaetano, Burke, George W, Gaynor, Jeffrey J, Sageshima, Junichiro, Herrada, Eva, Tueros, Lissett, Roth, David, Kupin, Warren, Rosen, Anne, Esquenazi, Violet, Miller, Joshua
Published in Transplantation (27.02.2008)
Published in Transplantation (27.02.2008)
Get more information
Journal Article
A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24months of follow-up
Ciancio, Gaetano, Burke, George W, Gaynor, Jeffrey J, Roth, David, Kupin, Warren, Rosen, Anne, Cordovilla, Tatiana, Tueros, Lissett, Herrada, Eva, Miller, Joshua
Published in Clinical transplantation (01.03.2008)
Published in Clinical transplantation (01.03.2008)
Get full text
Journal Article